The American Brachytherapy Society and Indian Brachytherapy Society consensus statement for the establishment of high-dose-rate brachytherapy programs for gynecological malignancies in low- and middle-income countries

The global cervical cancer burden is disproportionately high in low- and middle-income countries (LMICs), and outcomes can be governed by the accessibility of appropriate screening and treatment. High-dose-rate (HDR) brachytherapy plays a central role in cervical cancer treatment, improving local control and overall survival. The American Brachytherapy Society (ABS) and Indian Brachytherapy Society (IBS) collaborated to provide this succinct consensus statement guiding the establishment of brachytherapy programs for gynecological malignancies in resource-limited settings.

Source: Brachytherapy - September 11, 2023 Category: Cancer & Oncology Authors: Surbhi Grover, Katie E. Lichter, Anna Likhacheva, Joanne W. Jang, Matthew S. Ning, Tyler P. Robin, William Small, Rajat J. Kudchadker, Jamema Swamidas, Supriya Chopra, Bhavana Rai, Sunil Dutt Sharma, Daya N. Sharma, Thayalan Kuppusamy, Ruijie Yang, Daniel Source Type: research